Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT

Clinical trial NCT00861250 · COMPLETED

Trial details

NCT number: NCT00861250
Sponsor: Tampere University Hospital
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2009-03-01
Primary completion: 2014-12-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.